首页 | 本学科首页   官方微博 | 高级检索  
检索        

哌拉西林/他唑巴坦治疗老年慢性脓胸的临床疗效观察
引用本文:汪文东,何泽锋,王建军.哌拉西林/他唑巴坦治疗老年慢性脓胸的临床疗效观察[J].中华医院感染学杂志,2004,14(5):571-572.
作者姓名:汪文东  何泽锋  王建军
作者单位:华中科技大学同济医学院附属协和医院,湖北,武汉,430022
摘    要:目的研究哌拉西林/他唑巴坦治疗老年慢性脓胸的临床疗效及致病菌清除率. 方法同济医学院附属协和医院胸外科2001年3月~2003年7月30例老年慢性脓胸患者,分为治疗组和对照组,治疗组使用哌拉西林/他唑巴坦4.5 g,3~4次/d,静脉注射;对照组使用头孢他啶2.0 g,3~4次/d,静脉注射,主要观察治疗前后两组患者的临床疗效和细菌清除情况. 结果用哌拉西林/他唑巴坦治疗组临床总有效率、细菌清除率分别为87.50%和80.43%,明显优于对照组. 结论哌拉西林/他唑巴坦可以有效地治疗老年慢性脓胸.

关 键 词:哌拉西林/他唑巴坦  老年  慢性脓胸  临床疗效
文章编号:1005-4529(2004)05-0571-02
修稿时间:2003年10月18

Clinical Effect of Piperacillin/tazobactam in the Treatment of the Senile Chronic Empyema
WANG Wen-dong,HE Ze-feng,WANG Jian-jun.Clinical Effect of Piperacillin/tazobactam in the Treatment of the Senile Chronic Empyema[J].Chinese Journal of Nosocomiology,2004,14(5):571-572.
Authors:WANG Wen-dong  HE Ze-feng  WANG Jian-jun
Abstract:OBJECTIVE To investigate the clinical effect of piperacillin/tazobactam in the treatment of the senile chronic empyema. METHODS Thirty senile chronic empyema patients in the Department of Thoracic Surgery,Xiehe Hospital,Tongji Medical College,Huazhong University of Science and Technology,from Mar 2001 to Jul 2003,were divided into treatment group and control group. Treatment group: piperacillin/tazobactam 4.5 g, intravenous injection,tidor qid. Control group: ceftazidime 2.0 g,intravenous injection,tid or qid. The clinical effect and clearance of pathogenic bacteria of the two groups after the treatment were observed. RESULTS The effective rate and clearance of pathogenic bacteria of the treatment group (using piperacillin/tazobactam) were 87.50% and 80.43%,respectively,which were obviously higher than the control group. CONCLUSIONS Piperacillin/tazobactam could treat the senile chronic empyema effectively.
Keywords:Piperacillin/tazobactam  Senile  Chronic empyema  Clinical effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号